Pricing Log in Create free account

Palvella Therapeutics, Inc. (PVLA) vs Vera Therapeutics, Inc. (VERA)

Palvella Therapeutics, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Palvella Therapeutics, Inc. and Vera Therapeutics, Inc. are of similar size ($2.3B and $2.2B). Across the 10 metrics below, Palvella Therapeutics, Inc. leads on 9 and Vera Therapeutics, Inc. on 1.

Valuation

Metric PVLA VERA Biotechnology median
P/E n/m n/m 10.26
P/S 54.15 n/m 9.18
P/B 10.38 5.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 48.15 n/m 8.98
Earnings yield (3.08%) (19.32%) (34.89%)
Free cash flow yield (1.43%) (15.55%) (24.52%)

Profitability

Metric PVLA VERA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (46.63%) (91.75%) (50.12%)
Return on assets (37.70%) (72.32%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PVLA VERA Biotechnology median
Revenue growth (TTM) 146.67% — 6.26%
EPS growth (last fiscal year) 52.62% (69.45%) 29.88%
Revenue growth, 5-year CAGR 8.03% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PVLA VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 21.18 10.92 4.89
Net debt to EBITDA 1.50 2.00 1.01

Dividend

Metric PVLA VERA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PVLA VERA Biotechnology median
Market cap 2.26b 2.17b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack